s6y

LEXICON PHARMACEUTICALS, INC.

Ticker
LXRX
CIK
1062822
Industry
Pharmaceutical Preparations
Formerly
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX

Financials 111

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 111 financials filings

News 256

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 256 news filings

Ownership 776

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 776 ownership filings

Prospectus 84

  1. S-3 Registration statement for specified transactions by certain issuers
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  6. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  7. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. S-3 Registration statement for specified transactions by certain issuers

All 84 prospectus filings

Proxies 67

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 67 proxies filings

Other 112

  1. SCHEDULE 13G/A
  2. EFFECT Notice of Effectiveness
  3. SCHEDULE 13G/A
  4. SCHEDULE 13D/A
  5. ARS Annual report to security holders
  6. D Exempt (Private) Offering
  7. SCHEDULE 13D/A
  8. SCHEDULE 13G/A
  9. SCHEDULE 13G/A
  10. ARS Annual report to security holders

All 112 other filings